Related Experiment Video
Updated: Jul 2, 2026

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
Comparing single and repeated dosimetry data for perfluorooctane sulfonate in rats
Leona A Harris1, Hugh A Barton
1Department of Mathematics and Statistics, The College of New Jersey, Ewing, NJ 08628, USA. harrisl@tcnj.edu
Perfluorooctane sulfonate (PFOS) poses health risks due to its widespread environmental presence and toxicity. This study models PFOS disposition in rats to understand its pharmacokinetics and assess human health risks.
Area of Science:
- Environmental Chemistry
- Toxicology
- Pharmacokinetics
Background:
- Perfluorooctane sulfonate (PFOS) is a widely used chemical with oleophobic and hydrophobic properties.
- PFOS exhibits toxicity in laboratory animals and is prevalent in the environment, raising human health concerns.
- Limited pharmacokinetic data for PFOS in humans and rodents necessitates further investigation.
Purpose of the Study:
- To develop a mathematical model for PFOS disposition in adult rats.
- To understand PFOS pharmacokinetics following intravenous, oral, and chronic dietary exposures.
- To determine if single-dose kinetics predict repeated-dose kinetics for PFOS.
Main Methods:
- Development of a mathematical model for PFOS disposition in rats.
- Analysis of pharmacokinetic parameters including urinary and biliary clearance.
- Characterization of time-dependent and concentration-dependent changes in PFOS distribution.
Main Results:
- A mathematical model was created to describe PFOS disposition in rats.
- The model facilitates understanding of PFOS pharmacokinetics across different exposure routes.
- The study identified the need to characterize time- and concentration-dependent changes in PFOS clearance and liver distribution.
Conclusions:
- Rodent pharmacokinetic and toxicity data can aid in human risk assessment through cross-species extrapolation.
- Further research is required to determine if observed time-dependent changes in PFOS pharmacokinetics are due to experimental inconsistencies, aging, or chemical induction.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021